Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 245

Emailed: 0

PDF Downloaded: 1126


Biswas, Chaudhury, Mondal, Chattopadhyay, and Chatterjee: Serological evaluation of prevalence of TORCH amongst antenatal mothers attending a rural tertiary care hospital


Introduction

Bad obstetric history (BOH) is a condition where there is loss of the foetus in previous two/more pregnancies either as spontaneous abortions, intrauterine foetal death/stillbirth, congenital anomalies or preterm labour. BOH may be due to genetic, hormonal or due to prenatal/perinatal infections by the TORCH complex [Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), Herpes simplex virus type 1 and 2 (HSV 1 & 2)] or other agents—Chlamydia trachomatis, Treponema pallidum, Neisseria gonorrhoea, HIV and others.1 TORCH infections are usually asymptomatic causing little or no complications in the mother but serious adverse effects in the foetus.2

Toxoplasma gondii is an intracellular protozoa, transmitted through contaminated food/ water and undercooked meat. Within 5-25 days, cyst (the infective form) develops in the body causing Toxoplasmosis in man. After infection, the patient remains asymptomatic but when she becomes pregnant, may lose the foetus either as abortion, stillborn or may give birth to a congenitally malformed baby.3, 4

Rubella, an RNA virus gets transmitted via droplets and through placenta from mother to the foetus. The incubation period is for 2–3 weeks and the infection persist for 5 days.5 It causes mild or asymptomatic infection in children and adults but if it crosses the placental barrier, it leads to abortions, intra uterine foetal death, or congenitally malformed baby—the congenital rubella syndrome (CRS).6

Cytomegalovirus (CMV) is transmitted through saliva, urine, or genital secretions of the infected individual with man being the reservoir of the virus. 7 CMV may also causes apart from abortions---intrauterine growth retardation, microcephaly with intracranial calcification, hepatosplenomegaly, jaundice, chorioretinitis, thrombocytopenic purpura, anaemia in neonates8 leading to deafness, blindness, hearing, cerebral palsy like features, decreased coordination and even seizures. 9

Toxoplasma and CMV are the commonest infections being present in 40-45% of all the infections; 10 Rubella virus, however, affects only 10-20% women. 11

Herpes simplex virus is a very common infection worldwide. 3 It is of 2 types—HSV 1& 2. HSV1 is transmitted from non-sexually, while HSV2 is always transmitted via the genital tract causing genital herpes. 12, 13 Genital herpes infection in pregnant mothers leads to spontaneous abortion and prematurity. 14

Prevalence of TORCH infection in pregnant women is usually established serologically—identifying the presence of specific IgM/IgG antibodies in paired sera. The IgM antibody titre falls slowly becoming undetectable within 6 months. IgG appears within 3-4 weeks of infection and persists in low titres lifelong. 15 A positive IgG titre confirms previous infection with TORCH. 16

Studies on the role of TORCH in BOH mothers are few and hence the present study aims to establish this by evaluating the IgM antibody levels and their role in undetected abortions, stillbirths, and congenital anomalies.

Materials and Methods

A six months hospital based cross-sectional study March 2019 to August 2019 was carried out in the Microbiology Department of a rural tertiary care hospital of Eastern India. Approval from the Institutional Ethics Committee was attained. Informed consent was also taken from the pregnant women with history of undesirable pregnancy outcomes in earlier conceptions.

The inclusion criterion in our study was pregnant women with history of abortions/ intrauterine foetal deaths/preterm deliveries or congenital anomalies in their previous pregnancies.

Pregnant mothers giving history of high blood pressure, diabetes mellitus, Rh- incompatibility or others causes of previous pregnancy loss were excluded from the study.

97 pregnant women aged from 21-35 years were included in the study. Aseptically about 3 ml of blood was collected from each patient in a sterile container. Sera was extracted by centrifugation and kept at -200 C. IgM ELISA test was thereafter conducted in these serum samples using kits manufactured by Calbiotech (Cal#TX024M & Lot # TXM4546). Syphilis was excluded by RPR test and to exclude HIV 3 step immunodot assay was done.

Results

In this study, seropositivity of IgM antibodies against TORCH agents in 97 pregnant mothers between 21-35 years with history of BOH in their previous pregnancies was studied. They were followed up till their delivery to know the outcome of their present pregnancy. Maximum history of BOH was found in mothers aged between 26-30 years (50/97 i.e.51.55%) followed by the 21-25yrs [32/97 (32.99%)].

Table 1

Obstetrical history in different age groups in the study population

Outcome

21-25yrs

26-30 yrs

31-35 yrs

Total

Abortion

21

33

07

61

Intra-uterine death

07

09

04

20

Preterm delivery

04

07

03

14

Congenitalanomaly

00

01

01

02

Total

32(32.99%)

50(51.55%)

15(15.46%)

97(100%)

Of the 97 cases, ELISA detected the presence of IgM against TORCH in 20 cases (20.62%) -03cases/97 total BOH mothers (3.09%) against Toxoplasma, 06/97(6.19%) against Rubella, 09/97 (9.28%) against CMV and 02/97 (2.06%) against HSV 2.

Maximum mothers of the age group 26-30yrs showed the presence of IgM antibodies against the TORCH —2 (10%) against Toxoplasma, 3 (15%) against Rubella, 5(25%) against CMV and 2 (10%) against HSV 2 followed by the 21-25 yrs age group.

It has been also found that IgM antibody was detected highest against CMV in all the age groups of the BOH mothers 09 (45%). [Table 2]

Table 2

Sero-positivity of IgM to different members of the TORCH profile in different age groups

Age group

T oxoplasma IgM

Rubella IgM

Cyto-megalo virus (CMV) IgM

Herpes simplex virus 2 IgM

Total

21-25yrs

00

01

02

00

26-30yrs

02

03

05

02

31-35yrs

01

02

02

00

Total

03(15%)

06 (30%)

09 (45%)

02 (10%)

20 (100%)

All the mothers were followed up till their delivery to find the obstetrical outcome in their present pregnancy. Abortion was found to be the commonest outcome in mothers showing IgM seropositivity to Toxoplasma alone or with Rubella and mixed infection, mainly of CMV and Rubella. Congenital malformation of meningomyelocele was found in a mother with mixed infection of CMV & Toxoplasma. Full term delivery by Caesarean Section/vaginal delivery of apparently normal baby were found in 4 cases though these mothers had IgM mixed seropositivity to CMV, Rubella and HSV 2. [Table 3]

Table 3

Association between IgM & obstetrical outcome in study group due to torch agents

Outcome

IgM

Type of infection

Abortion

08

Toxoplasma, Toxoplasma & CMV, CMV & Rubella

Intra-uterine death

05

CMV, CMV & Rubella

Preterm delivery

02

Rubella, CMV & Rubella

Congenitalanomaly

01

CMV & Toxoplasma

Normal delivery

02

CMV & Rubella, CMV

Caesearian section

02

CMV & HSV2.

Total

20 (100%)

-

Discussion

Our study show that the TORCH agents are important causes of BOH in pregnant women and being significantly responsible for pregnancy loss. 17 These infections leads to neonatal mortality and perinatal/childhood morbidity. 18 Except HSV2, rest of the TORCH agents causes an infection in the mother infecting the placenta and the foetus. HSV 2 virus is present as a latent infection in the genital tract of these infected mothers which becomes active with pregnancy--moves up and infects the foetus. 19

Persistent encysted forms of Toxoplasma present in the infected uterus spreads to the placenta causing infection to the baby in the first trimester terminating in abortion.

The IgM antibodies against Toxoplasma gondii were detected between 7.7%-76.7percent in different studies. We, however, found IgM antibodies against Toxoplasma gondii in 3.09% cases which is in concordance with a study undertaken by Padmavathy M et al who found a seropositivity of IgM antibodies of 5.8%.

Rubella is a rubivirus which causes mild infection in patients. WHO states that every year, 1 lakh children are born with (combination of deafness, cataract, cardiac complications) congenital rubella syndrome specially in developing countries. Rubella IgM antibodies produces lifelong immunity 18 and primary viral infection during pregnancy may cause foetal damage. 18, 19

The seropositivity of rubella IgM antibodies in our study amongst 97 BOH mothers was 06/97(6.19%). IgM positivity of 4.66%, 4.6% and 6.5% in BOH mothers was reported by Surpam RB et al, Padmavathy M et al and Yasodhara et al respectively.

Against CMV, we found a high seropositivity of IgM antibodies (09/97, 9.28%) similar to Padmavathy M et al (9.2%).

CMV persists in the body indefinitely as a latent infection (Collennberge et al., 2006). Pregnancy probably reactivates the latent virus leading to reproductive loss. Primary CMV infection causes symptomatic infection in the foetus and ultimately foetal death. But in adults the infection is asymptomatic and is difficult to diagnose clinically. 1

Primary infection or reactivation of an old infection in pregnant mothers during pregnancy leads to the mortality and morbidity due to HSV 2 in neonates. Studies have opined that primary infection of HSV in 1st/2nd trimester pregnancy leads to increased rate of spontaneous abortion and/or prematurity and growth retardation of the foetus.

We found a seropositivity of IgM antibodies (02/97, 2.06%) in our study against HSV 2 which is similar to the result obtained by Padmavathy M et al (2.3%). IgM seropositivity of 3.6% and 3.3% was reported by Turbakar et al and Janak et al.

Congenital infections due to TORCH (Toxoplasma gondii, Rubella, CMV) thus is responsible for a large number of neonatal and early childhood morbidity/mortality worldwide and it has also been re-established by our study. We also found that TORCH is responsible for a large number of adverse consequences in pregnancy-abortion being the commonest end result (08/97, 8.25%).

Conclusion

Thus in conclusion, based on our study, we have found that TORCH infections play an important role in adverse consequences of pregnancy. Therefore it is advisable that all antenatal mothers be routinely screened for TORCH because early diagnosis and interventions may lead to decreased foetal morbidity and mortality.

Conflict of Interest

None.

Source of Funding

None.

References

1 

D Turbadkar M Mathur M Rele Seroprevalence of TORCH infection in Bad obstetric historyIndian J Med Microbiol200321210810

2 

R Kaur N Gupta D Nair M Kakkar MD Mathur Screening for TORCH infections in pregnant women: A report from DelhiSoutheast Asian J Trop Med Public Health19993022846

3 

K R Prasoona B Srinadh T Sunitha M Sujatha MLN Deepika LB Vijaya Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South IndiaJ Obstet Gynaecol India2015655301910.1007/s13224-014-0615-3

4 

JG Montoya JS Remington GL Mandel JE Bennett R Dolin Toxoplasma gondiiMandell, Douglas, and Bennetts’Principles and Practice of Infectious Diseases5th Edn.Churchill LivingstonePhiladelphia2000285888

5 

R Verma P Khanna S Chawla Rubella vaccine: new horizon in prevention of congenital rubella syndrome in the IndiaHum Vaccin Immunother201286831310.4161/hv.19584

6 

JY Lee DS Bowden Rubella virus replication and links to teratogenicityClin Microbiol Rev20001345718710.1128/CMR.13.4.571

7 

KB Fowler RF Pass Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activityPediatrics200611822869210.1542/peds.2005-1142

8 

Z Al-Hareth F Monem NA Megiud Is low birth weight a risk indicator for congenital cytomegalovirus infectionJ Infect Dev Ctries20104144710.3855/jidc.539

9 

SC Dollard SD Grosse DS Ross New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infectionRev Med Virol20071753556310.1002/rmv.544

10 

MD Sarkar B Anuradha N Sharma Seropositivity of Toxoplasmosis in antenatal women with bad obstetric history in a tertiary care hospital of Andhra PradeshIndia. J Health Popul Nutr20123018792

11 

M Padmavathy M Gowri J Malini B L Umapathy B V Navaneeth M Bhatia Seroprevalence of TORCH infections and adverse reproductive outcome in current pregnancy with bad obstetric historyJ Clin Biomed Sci2013326271

12 

E Anzivino D Fioriti M Mischitelli A Bellizzi V Barucca F Chiarini Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and preventionVirol J200964010.1186/1743-422X-6-40

13 

M Cusini M Ghislanzoni The importance of diagnosing genital herpesJ Antimicrob Chemother200147Suppl T1916 10.1093/jac/47.suppl_1.9

14 

D Biswas B Borkakoty J Mahanta K Walia L Saikia BS Akoijam Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast IndiaBMC Infect Dis20111132510.1186/1471-2334-11-325

15 

L Gras R E Gilbert M Wallon F Peyron M Cortina-Borja Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: Implications for clinical practice and cross-sectional incidence studiesEpidemiol Infect20041323541810.1017/s0950268803001948

16 

AH Razzak SA Wais AY Saeid Toxoplasmosis: the innocent suspect of pregnancy wastage in Duhok, IraqIraq. Eas Med Health200511462532

17 

S Sood P Pillai C Raghunath Infection as a cause of spontaneous abortion with special reference to Toxoplasma gondii, rubella virus, CMV and Treponema pallidumIndian J Med Microbiol1994122047

18 

MJ Binnicker DJ Jespersen JA Harring Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, Rubella virus and cytomegalovirus using a novel multiplex flow immunoassayClin Vaccine Immunol201017111734810.1128/CVI.00332-10

19 

K Janak M Richa P Abhiruchi P Yashodhara Adverse reproductive outcome induced by parvovirus B19 and TORCH infections in women with high risk pregnancyJ Infect Dev Ctries20115128687310.3855/jidc.1533



jats-html.xsl

© 2023 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)